InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Kayitalire Louis, Directeur Médical. Insider active across 1 company, notably F-star Therapeutics, Inc.. In total, 9 disclosures have been logged. Split: 0 buy · 6 sells. Total volume traded: €16k. Activity tracked since 2 July 2021. The latest transaction was disclosed on 8 March 2023 (U). Regulator: SEC (Form 4). The full history is openly available.
Declarations9 total
29,236 shares@ US$7.1292.4% of flowCommon StockSEC:0000899243-23-007670:0
39 shares@ US$6.811.4% of flowCommon StockSEC:0001209191-21-063046:0
39 shares@ US$6.810.1% of flowCommon StockSEC:0001209191-21-063046
64 shares@ US$7.22562.4% of flowCommon StockSEC:0001209191-21-059842:0
64 shares@ US$7.22560.2% of flowCommon StockSEC:0001209191-21-059842
26,437 shares0Common StockSEC:0001209191-21-053224:0
26,437 shares0Common StockSEC:0001209191-21-053224
1,054 shares@ US$8.433.5% of flowCommon StockSEC:0001209191-21-045957
1,054 shares@ US$8.4346.1% of flowCommon StockSEC:0001209191-21-045957:0
9 of 9 declarations
About Kayitalire Louis
Kayitalire Louis serves as the Chief Medical Officer at F-star Therapeutics, Inc. In this role, he is responsible for leading the company's medical and research initiatives. Louis oversees clinical programs and ensures that quality and safety standards are met in the development of treatments. His medical expertise is essential for innovation and the success of F-star Therapeutics.
